TNMG — TNL Mediagene Income Statement
0.000.00%
- $10.81m
- $21.74m
- $48.49m
Annual income statement for TNL Mediagene, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 20 | 35.8 | 48.5 |
Cost of Revenue | |||
Gross Profit | 7.74 | 12.7 | 17.7 |
Selling / General / Administrative Expenses | |||
Research And Development | |||
Unusual Expense / Income | |||
Total Operating Expenses | 23.4 | 42.9 | 125 |
Operating Profit | -3.42 | -7.1 | -76.3 |
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | -11.6 | -1.81 | -85.3 |
Provision for Income Taxes | |||
Net Income After Taxes | -11.4 | -1.22 | -85 |
Minority Interest | |||
Net Income Before Extraordinary Items | |||
Net Income | -11 | -0.796 | -84.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | -11 | -0.796 | -84.9 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | -0.454 | -0.033 | -2.73 |